Parsons Corporation (PSN) Selected to Support U.S. Army Chemical and Biological Defense


News and research before you hear about it on CNBC and others. Claim your one week free trial for StreetInsider Premium here.

Parsons Corporation (NYSE:PSN) has been selected by the U.S. Army Combat Capabilities Development Command, Chemical Biological Center (DEVCOM CBC) for an award for its Indefinite Delivery, Indefinite Quantity (IDIQ) contract for scientific, technical, and program support (STEPSS) . The 10-year IDIQ, a multi-award contract with a maximum program value of $869 million, will support the U.S. military by providing defense research, development, test, and evaluation support chemical and biological acquisition life cycle.

“We stand ready to support DEVCOM CBC as they realize their vision to deliver innovative chemical and biological defense capabilities to advance national security and global combat operations,” said Jon Moretta, business unit president. Parsons Engineering Systems. “This is an exciting win as we continue to build our capabilities in the biomonitoring and environmental sector. We look forward to bringing our proven talent, expertise and critical solutions to this important mission. »

STEPSS technical support tasks can include research, development, testing, and evaluation; engineering, system acquisition and development of engineering systems; and chemical and biological demilitarization operations. Parsons Biomonitoring and Environment business is a mission-driven group of experts, technologies and products to keep humans healthy and safe from known and emerging biological threats, contaminants chemicals and other hazards.

This award continues the company’s decades of experience providing innovative chemical and biological defense solutions and services to the federal sector, including the U.S. Army Medical Research Command, Naval Health Research Center, and Naval Medical Research Center, as well as program management support for all major DoD medical organizations, including the Department of Veterans Affairs and individual branch medical services.

To learn more about Parsons’ capabilities in the life sciences, visit

Source link


Comments are closed.